Australian Broker Call
Produced and copyrighted by at www.fnarena.com
September 09, 2021
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).
Last Updated: 05:00 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
FMG - | Fortescue Metals | Upgrade to Buy from Neutral | Citi |
IMD - | Imdex | Upgrade to Outperform from Neutral | Macquarie |
MQG - | Macquarie Group | Downgrade to Hold from Add | Morgans |
TNE - | Technology One | Downgrade to Neutral from Buy | UBS |
ANN ANSELL LIMITED
Commercial Services & Supplies
More Research Tools In Stock Analysis - click HERE
Overnight Price: $36.73
Citi rates ANN as Buy (1) -
Citi expects Ansell will be net cash by the end of FY23. Beyond the pandemic, the ungeared balance sheet provides further upside potential from either M&A and/or share buybacks, which the broker does not include in forecasts.
Sales are expected to normalise in FY23 when growth rates return to normal. Buy rating and $46.50 target maintained.
Target price is $46.50 Current Price is $36.73 Difference: $9.77
If ANN meets the Citi target it will return approximately 27% (excluding dividends, fees and charges).
Current consensus price target is $43.84, suggesting upside of 20.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 117.07 cents and EPS of 257.68 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 248.9, implying annual growth of N/A. Current consensus DPS estimate is 109.4, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 14.6. |
Forecast for FY23:
Citi forecasts a full year FY23 dividend of 113.08 cents and EPS of 224.03 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 240.3, implying annual growth of -3.5%. Current consensus DPS estimate is 110.1, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 15.2. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.85
Macquarie rates BGL as Resume Coverage with Outperform (1) -
Macquarie resumed coverage of Bellevue Gold after a short hiatus with an Outperform rating and $I.40 target.
The stage 2 study has boosted production in the first five years to 200,000 ounces per annum and a $306m funding package will now mean the project can advance to production. Reducing exploration expenditure improves the broker's estimates for FY22 by 37%.
Current Price is $0.85. Target price not assessed.
The company's fiscal year ends in June.
Forecast for FY21:
Macquarie forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 0.90 cents. |
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.50 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.46
Morgans rates COF as Hold (3) -
Centuria Office has acquired two assets in Sydney and Melbourne for $273.1m. The acquisitions will be funded via an entitlement issue and debt. Morgans observes the portfolio is stable and investor demand is still strong.
A successful roll-out of vaccines will continue to improve sentiment regarding a return to the office as well as increase confidence in the economic outlook.
FY22 guidance is unchanged with a distribution of 16.6c. Morgans retains a Hold rating and reduces the target to $2.48 from $2.50.
Target price is $2.48 Current Price is $2.46 Difference: $0.02
If COF meets the Morgans target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $2.48, suggesting upside of 0.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgans forecasts a full year FY22 dividend of 16.60 cents and EPS of 18.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 18.3, implying annual growth of 23.0%. Current consensus DPS estimate is 16.9, implying a prospective dividend yield of 6.8%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY23:
Morgans forecasts a full year FY23 dividend of 17.00 cents and EPS of 18.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 18.9, implying annual growth of 3.3%. Current consensus DPS estimate is 17.0, implying a prospective dividend yield of 6.9%. Current consensus EPS estimate suggests the PER is 13.1. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $17.92
Citi rates FMG as Upgrade to Buy from Neutral (1) -
Citi upgrades Fortescue Metals to Buy from Neutral and reduces the target to $18.50 from $19.50. The broker suspects iron ore could hold at levels over US$100/t for longer than the market is currently factoring.
Longer-dated market concerns regarding large-scale iron ore exports from Guinea now look much less certain. Moreover, China's leading indicators are stabilising and have headed higher from recent lows.
Target price is $18.50 Current Price is $17.92 Difference: $0.58
If FMG meets the Citi target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $21.18, suggesting upside of 18.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 325.93 cents and EPS of 408.14 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 407.3, implying annual growth of N/A. Current consensus DPS estimate is 318.1, implying a prospective dividend yield of 17.8%. Current consensus EPS estimate suggests the PER is 4.4. |
Forecast for FY23:
Citi forecasts a full year FY23 dividend of 163.63 cents and EPS of 204.07 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 231.1, implying annual growth of -43.3%. Current consensus DPS estimate is 198.2, implying a prospective dividend yield of 11.1%. Current consensus EPS estimate suggests the PER is 7.7. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $6.40
UBS rates GNC as Buy (1) -
ABARES has estimated a 26.5mt winter crop on the east cost in FY22. This remains below the bumper crop of 29.9mt in FY21 yet UBS highlights ABARES delivered two further upgrades to its second crop estimate in FY21.
The broker raises its FY22 EBITDA forecasts for GrainCorp by 14% to $290m. A Buy rating is retained despite the strong share price performance, given the chance of further upgrades should ABARES lift forecasts again, which also increasingly de-risks FY23.
There is also potential for capital management and an undemanding valuation. Target is raised to $7.20 from $7.00.
Target price is $7.20 Current Price is $6.40 Difference: $0.8
If GNC meets the UBS target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $6.86, suggesting upside of 8.2% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY21:
UBS forecasts a full year FY21 EPS of 56.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 57.6, implying annual growth of 106.9%. Current consensus DPS estimate is 29.9, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 11.0. |
Forecast for FY22:
UBS forecasts a full year FY22 EPS of 50.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 58.0, implying annual growth of 0.7%. Current consensus DPS estimate is 32.9, implying a prospective dividend yield of 5.2%. Current consensus EPS estimate suggests the PER is 10.9. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.33
Macquarie rates IMD as Upgrade to Outperform from Neutral (1) -
Macquarie considers the earnings outlook is positive given the latest data that show a continuation of favourable industry inputs. Rating is upgraded to Outperform from Neutral.
The main risks to the rating include a material downturn in gold and copper prices or disruptions caused by the pandemic to operations in Australia and North America. Target is raised to $2.65 from $2.56.
Target price is $2.65 Current Price is $2.33 Difference: $0.32
If IMD meets the Macquarie target it will return approximately 14% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 3.50 cents and EPS of 10.70 cents. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 4.30 cents and EPS of 12.20 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.66
Ord Minnett rates INR as Buy (1) -
Ord Minnett expects momentum can be maintained amidst a tight lithium market. The price of litium continues to surge, up 150% in the year to date. Inventory levels appear low and peak sesasonal demand is approaching.
The broker considers the stock unique and strategically positioned and reiterates a Speculative Buy rating. Target is raised to $0.75 from $0.55.
Target price is $0.75 Current Price is $0.66 Difference: $0.09
If INR meets the Ord Minnett target it will return approximately 14% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Ord Minnett forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 0.40 cents. |
Forecast for FY22:
Ord Minnett forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.20 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $51.70
Macquarie rates MIN as Outperform (1) -
The Lockyer Deep-1 well has successfully encountered gas in the Perth Basin. Macquarie is encouraged by the announcement and should the flow test prove successful Mineral Resources will be able to accelerate its plans to switch to LNG from diesel fuel at its mining operations throughout Western Australia.
The broker does not include any value currently for the well or the switch to LNG, yet incorporates the sale of the investment in Pilbara Minerals ((PLS)). Outperform rating and $77 target maintained.
Target price is $77.00 Current Price is $51.70 Difference: $25.3
If MIN meets the Macquarie target it will return approximately 49% (excluding dividends, fees and charges).
Current consensus price target is $60.12, suggesting upside of 19.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 257.00 cents and EPS of 566.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 675.8, implying annual growth of 0.4%. Current consensus DPS estimate is 300.8, implying a prospective dividend yield of 6.0%. Current consensus EPS estimate suggests the PER is 7.4. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 229.00 cents and EPS of 511.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 495.9, implying annual growth of -26.6%. Current consensus DPS estimate is 187.7, implying a prospective dividend yield of 3.7%. Current consensus EPS estimate suggests the PER is 10.1. |
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MQG MACQUARIE GROUP LIMITED
Wealth Management & Investments
More Research Tools In Stock Analysis - click HERE
Overnight Price: $179.13
Citi rates MQG as Sell (5) -
Macquarie Group has guided to first half net profit to be slightly lower than the prior half which, Citi suggests, implies a range of $I.8-2.0bn.
The broker expects earnings will moderate in the second half of FY22 as the gain on the UK metres sale and buoyant capital markets are cycled.
The stock has reacted in a positive way to the improved outlook and Citi considers it expensive, retaining a Sell rating. Target is raised to $153 from $140.
Target price is $153.00 Current Price is $179.13 Difference: minus $26.13 (current price is over target).
If MQG meets the Citi target it will return approximately minus 15% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $174.82, suggesting downside of -0.1% (ex-dividends)
The company's fiscal year ends in March.
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 520.00 cents and EPS of 894.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of 8.1%. Current consensus DPS estimate is 553.6, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 19.2. |
Forecast for FY23:
Citi forecasts a full year FY23 dividend of 520.00 cents and EPS of 805.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of N/A. Current consensus DPS estimate is 576.0, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 19.2. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Credit Suisse rates MQG as Neutral (3) -
Macquarie Group has provided a positive update for the first half and Credit Suisse notes improved trading conditions as well as increased balance sheet deployment, which should drive earnings in the future from investment realisations.
The broker notes the Waddell & Reed acquisition also derived more positive commentary from the company. Neutral rating maintained. Target is raised to $175 from $150.
Target price is $175.00 Current Price is $179.13 Difference: minus $4.13 (current price is over target).
If MQG meets the Credit Suisse target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $174.82, suggesting downside of -0.1% (ex-dividends)
The company's fiscal year ends in March.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 577.00 cents and EPS of 962.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of 8.1%. Current consensus DPS estimate is 553.6, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 19.2. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 558.00 cents and EPS of 929.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of N/A. Current consensus DPS estimate is 576.0, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 19.2. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates MQG as Overweight (1) -
First half guidance was ahead of Morgan Stanley's expectations and a positive reaction is expected in the share price. While the stock has outperformed the ASX200 by 8% in the past month the broker retains an Overweight rating given the infrastructure and renewables momentum.
Macquarie Group is guiding for slower commodities earnings, albeit not significantly lower, and there is more confidence in the gains on sales in the pipeline.
The $175 target price is maintained. Industry view in-line.
Target price is $175.00 Current Price is $179.13 Difference: minus $4.13 (current price is over target).
If MQG meets the Morgan Stanley target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $174.82, suggesting downside of -0.1% (ex-dividends)
The company's fiscal year ends in March.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 550.00 cents and EPS of 845.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of 8.1%. Current consensus DPS estimate is 553.6, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 19.2. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 605.00 cents and EPS of 908.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of N/A. Current consensus DPS estimate is 576.0, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 19.2. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates MQG as Downgrade to Hold from Add (3) -
Morgans upgrades FY22 and FY23 estimates for earnings per share by 8% and 3%, respectively, to reflect Macquarie Group's more positive outlook. Macquarie Group expects first half net profit to be only slightly lower compared with the prior half's strong performance.
The business is exposed to structural growth areas and capitalising well on the current environment, with the broker noting some value accretive acquisitions.
Yet, with the stock running hard and now trading on 20x FY22 PE it is close to fair value and the broker downgrades to Hold from Add. Target is raised to $181.10 from $172.30.
Target price is $181.10 Current Price is $179.13 Difference: $1.97
If MQG meets the Morgans target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $174.82, suggesting downside of -0.1% (ex-dividends)
The company's fiscal year ends in March.
Forecast for FY22:
Morgans forecasts a full year FY22 dividend of 581.00 cents and EPS of 917.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of 8.1%. Current consensus DPS estimate is 553.6, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 19.2. |
Forecast for FY23:
Morgans forecasts a full year FY23 dividend of 617.00 cents and EPS of 956.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of N/A. Current consensus DPS estimate is 576.0, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 19.2. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates MQG as Accumulate (2) -
Macquarie Group has guided to first half earnings being "slightly down" on the prior half. Ord Minnett interprets this to mean a near doubling of earnings compared with a year ago.
The broker remains confident in the medium to long-term growth prospects and does not consider the PE multiple stretched versus the ASX200 Industrials.
Ord Minnett maintains an Accumulate rating and raises the target to $190 from $172.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $190.00 Current Price is $179.13 Difference: $10.87
If MQG meets the Ord Minnett target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $174.82, suggesting downside of -0.1% (ex-dividends)
The company's fiscal year ends in March.
Forecast for FY22:
Ord Minnett forecasts a full year FY22 dividend of 540.00 cents and EPS of 938.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of 8.1%. Current consensus DPS estimate is 553.6, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 19.2. |
Forecast for FY23:
Ord Minnett forecasts a full year FY23 dividend of 580.00 cents and EPS of 958.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 911.3, implying annual growth of N/A. Current consensus DPS estimate is 576.0, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 19.2. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NWH NRW HOLDINGS LIMITED
Mining Sector Contracting
More Research Tools In Stock Analysis - click HERE
Overnight Price: $1.82
Macquarie rates NWH as Outperform (1) -
NRW Holdings has secured the $290m EPC contract at Mount Holland. Macquarie observes the order book and outlook for FY22 remain strong and margin improvement is expected.
The tender pipeline of $14.5bn is also considered healthy. The broker highlights the business is highly leveraged to iron ore, coal and lithium expenditure. Outperform rating retained. Target is $2.20.
Target price is $2.20 Current Price is $1.82 Difference: $0.38
If NWH meets the Macquarie target it will return approximately 21% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 10.00 cents and EPS of 20.70 cents. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 10.00 cents and EPS of 20.50 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $11.94
Macquarie rates QBE as Neutral (3) -
Macquarie analyses the expense base to assess further cost reduction opportunities. The group cost base is already better than global averages and the broker concludes that the new CEO may find it difficult to remove more costs without negatively affecting revenue.
In the short term the US hurricane season is the most significant catalyst. Macquarie retains a Neutral rating and reduces the target to $12.10 from $12.40.
Target price is $12.10 Current Price is $11.94 Difference: $0.16
If QBE meets the Macquarie target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $13.94, suggesting upside of 18.4% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY21:
Macquarie forecasts a full year FY21 dividend of 34.32 cents and EPS of 70.37 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 79.0, implying annual growth of N/A. Current consensus DPS estimate is 53.8, implying a prospective dividend yield of 4.6%. Current consensus EPS estimate suggests the PER is 14.9. |
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 52.42 cents and EPS of 99.24 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 97.2, implying annual growth of 23.0%. Current consensus DPS estimate is 76.2, implying a prospective dividend yield of 6.5%. Current consensus EPS estimate suggests the PER is 12.1. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
QUB QUBE HOLDINGS LIMITED
Transportation & Logistics
More Research Tools In Stock Analysis - click HERE
Overnight Price: $3.42
Citi rates QUB as Buy (1) -
Qube Holdings has acquired the Newcastle agricultural terminal, and export grain facility, for $90m. Citi expects the supply chain environment will remain strong and consensus estimates for FY22 will be exceeded because of contract wins, acquisitions and capital management.
Moreover, the recycling of capital will normalise multiples and drive earnings momentum that will attract flows from a larger investor base. Buy rating and $3.45 target maintained.
Target price is $3.45 Current Price is $3.42 Difference: $0.03
If QUB meets the Citi target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $3.21, suggesting downside of -2.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 6.40 cents and EPS of 8.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 8.8, implying annual growth of 82.2%. Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.9%. Current consensus EPS estimate suggests the PER is 37.3. |
Forecast for FY23:
Citi forecasts a full year FY23 dividend of 7.20 cents and EPS of 9.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 10.3, implying annual growth of 17.0%. Current consensus DPS estimate is 6.7, implying a prospective dividend yield of 2.0%. Current consensus EPS estimate suggests the PER is 31.8. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $108.17
Citi rates RIO as Buy (1) -
Citi suspects iron ore could hold at levels over US$100/t for longer than the market is currently factoring.
Longer-dated market concerns regarding large-scale iron ore exports from Guinea now look much less certain. Moreover, China's leading indicators are stabilising and have headed higher from recent lows.
The broker argues the fact steel prices have stayed high points to consumption being driven more by state-imposed production restrictions rather than weakness in underlying demand.
Citi retains a Buy rating and reduces the target to $125 from $135.
Target price is $125.00 Current Price is $108.17 Difference: $16.83
If RIO meets the Citi target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $132.00, suggesting upside of 25.1% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY21:
Citi forecasts a full year FY21 dividend of 1999.47 cents and EPS of 2150.06 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 2076.5, implying annual growth of N/A. Current consensus DPS estimate is 1633.8, implying a prospective dividend yield of 15.5%. Current consensus EPS estimate suggests the PER is 5.1. |
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 1559.13 cents and EPS of 1788.48 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 1492.2, implying annual growth of -28.1%. Current consensus DPS estimate is 1134.4, implying a prospective dividend yield of 10.8%. Current consensus EPS estimate suggests the PER is 7.1. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $11.71
UBS rates TNE as Downgrade to Neutral from Buy (3) -
UBS resumes coverage with a downgrade to Neutral from Buy and $11.70 price target, transfering coverage to another analyst.
The broker forecasts 14% growth in pre-tax profit in FY21-26 and half of this growth is likely to be driven by the migration of the majority of existing customers to the SaaS platform.
The broker is more cautious on the remaining uplift, which is likely to be driven by product/mix and UK expansion. While the recent acquisition of Scientia should assist the UK expansion, UBS does not believe it will provide substantial upside.
Target price is $11.70 Current Price is $11.71 Difference: minus $0.01 (current price is over target).
If TNE meets the UBS target it will return approximately minus 0% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $10.10, suggesting downside of -11.9% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY21:
UBS forecasts a full year FY21 dividend of 13.00 cents and EPS of 23.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 22.1, implying annual growth of 11.9%. Current consensus DPS estimate is 13.5, implying a prospective dividend yield of 1.2%. Current consensus EPS estimate suggests the PER is 51.9. |
Forecast for FY22:
UBS forecasts a full year FY22 dividend of 17.00 cents and EPS of 26.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 24.5, implying annual growth of 10.9%. Current consensus DPS estimate is 16.2, implying a prospective dividend yield of 1.4%. Current consensus EPS estimate suggests the PER is 46.8. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Today's Price Target Changes
Company | Last Price | Broker | New Target | Prev Target | Change | |
BGL | Bellevue Gold | $0.83 | Macquarie | N/A | 1.30 | -100.00% |
COF | Centuria Office REIT | $2.47 | Morgans | 2.48 | 2.50 | -0.80% |
FMG | Fortescue Metals | $17.85 | Citi | 18.50 | 19.50 | -5.13% |
GNC | GrainCorp | $6.34 | UBS | 7.20 | 7.00 | 2.86% |
IMD | Imdex | $2.26 | Macquarie | 2.65 | 2.56 | 3.52% |
INR | ioneer | $0.63 | Ord Minnett | 0.75 | 0.55 | 36.36% |
MQG | Macquarie Group | $175.05 | Citi | 153.00 | 140.00 | 9.29% |
Credit Suisse | 175.00 | 150.00 | 16.67% | |||
Morgans | 181.10 | 172.30 | 5.11% | |||
Ord Minnett | 190.00 | 172.00 | 10.47% | |||
QBE | QBE Insurance | $11.78 | Macquarie | 12.10 | 12.40 | -2.42% |
RIO | Rio Tinto | $105.49 | Citi | 125.00 | 135.00 | -7.41% |
TNE | Technology One | $11.46 | UBS | 11.70 | N/A | - |
Summaries
ANN | Ansell | Buy - Citi | Overnight Price $36.73 |
BGL | Bellevue Gold | Resume Coverage with Outperform - Macquarie | Overnight Price $0.85 |
COF | Centuria Office REIT | Hold - Morgans | Overnight Price $2.46 |
FMG | Fortescue Metals | Upgrade to Buy from Neutral - Citi | Overnight Price $17.92 |
GNC | GrainCorp | Buy - UBS | Overnight Price $6.40 |
IMD | Imdex | Upgrade to Outperform from Neutral - Macquarie | Overnight Price $2.33 |
INR | ioneer | Buy - Ord Minnett | Overnight Price $0.66 |
MIN | Mineral Resources | Outperform - Macquarie | Overnight Price $51.70 |
MQG | Macquarie Group | Sell - Citi | Overnight Price $179.13 |
Neutral - Credit Suisse | Overnight Price $179.13 | ||
Overweight - Morgan Stanley | Overnight Price $179.13 | ||
Downgrade to Hold from Add - Morgans | Overnight Price $179.13 | ||
Accumulate - Ord Minnett | Overnight Price $179.13 | ||
NWH | NRW Holdings | Outperform - Macquarie | Overnight Price $1.82 |
QBE | QBE Insurance | Neutral - Macquarie | Overnight Price $11.94 |
QUB | Qube Holdings | Buy - Citi | Overnight Price $3.42 |
RIO | Rio Tinto | Buy - Citi | Overnight Price $108.17 |
TNE | Technology One | Downgrade to Neutral from Buy - UBS | Overnight Price $11.71 |
RATING SUMMARY
Rating | No. Of Recommendations |
1. Buy | 11 |
2. Accumulate | 1 |
3. Hold | 5 |
5. Sell | 1 |
Thursday 09 September 2021
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.
Latest News
1 |
The Short Report – 05 Dec 202410:29 AM - Weekly Reports |
2 |
Collins Foods, The Earnings Comeback Kid?10:00 AM - Australia |
3 |
The Overnight Report: AI Shines Yet Again9:19 AM - Daily Market Reports |
4 |
Today’s Financial Calendar – 05-12-20248:15 AM - Daily Market Reports |
5 |
ASX Winners And Losers Of Today – 04-12-24Dec 04 2024 - Daily Market Reports |